In a phase 2 study, Ojemda (tovorafenib) led to responses in 43% of adults with melanoma or other solid tumors that carried rare RAF gene changes. Ojemda (tovorafenib) shrank tumors in 10 of 23 adults ...

Neoadjuvant Immunotherapy Is Here to Stay / cancer care, Cancer research, immunotherapy, James Larkin, Leslie Fecher, ...

Wu, Department of Dermatology, University of Utah, Salt Lake City, and colleagues evaluated whether a family-focused ...

It's not a cure for baldness. But it might eliminate crow's feet and laugh lines by telling the tissues in your face how to ...

Moderna Inc MRNA shares are rising Friday to a fresh 52-week high. The stock enters the Nasdaq-100 Index. Here’s what you should know. Moderna stock is at critical resistance. Why is MRNA stock ...

Moderna stock gains on reports of an initiative to accelerate cancer vaccine development. Here’s why caution is warranted in ...

A three-drug combination helped treatment-resistant melanoma respond again to immune-based therapy in mouse experiments. The ...

The biotech could play a significant role in a national effort to combat cancer.

The “weaker sex” myth has never been less true than it is today, when scientific evidence about the strength, intelligence, ...

The Bama Theater in Tuscaloosa hosted the premiere of ESPN’s six-part series Saban on Thursday night. ESPN sideline reporter Holly Rowe was among those at the premiere.

PTC Soars Over 35%; Moderna Hits New High in More Than Four Years; Energy and SpaceX Partnership Concepts Show Strong ...

Moderna (MRNA) stock surged 14% after reports of a new NIH cancer research initiative and encouraging trial data with Merck.